surpass-2 tirzepatide vs semaglutide weight loss Cardiovascular outcomes of and for patients with type 2 diabetes in clinical practice Frias_Tirzepatide: Overview of SURPASS Trials

The injection site, technique, and frequency remain constant

A study showed that diabetic patients taking semaglutide were over four times more likely to be diagnosed with NAION than those on other medications

Melanotan-1 won't improve sexual function

The FDA does not recognize HCG as safe or effective for weight loss, and any claims linking HCG to fat reduction remain anecdotal

They were also less likely to experience a documented opioid poisoning event over the study window, with 7% having such an event, versus 16% for those without a prescription (see Figure below)

The FDA subsequently approved certain higher-dose formulations specifically for chronic weight management in adults with obesity or weight-related health conditions